Latest Breaking News On - Sacituzumab govitecan plus pembrolizumab - Page 1 : comparemela.com

EVOKE-02: Sacituzumab Govitecan Plus Pembrolizumab in Advanced NSCLC

Edward B. Garon, MD, MS, reviews data from the EVOKE-02 study, and the panel offers their thoughts on antibody-drug conjugates for the treatment of advanced NSCLC.

Edwardb garonEvolving treatment paradigmAdvanced nonSmall cell lung cancerSacituzumab govitecan plus pembrolizumabNon small cell lung cancerAdvanced non small cell lung cancerAdvanced nsclcNsclc treatmentEvoke 02Antibody drug conjugatesSacituzumab govitecan

Dr Grivas on Sacituzumab Govitecan Plus Pembrolizumab in Metastatic Urothelial Cancer

Petros Grivas, MD, PhD, discusses findings from the primary analysis of cohort 3 of the phase 2 TROPHY U-01 trial in patients with metastatic urothelial cancer.

Petros grivasGenitourinary cancers programDivision of oncologyDepartment of medicineUniversity of washington school medicineClinical research divisionFred hutch cancer centerUniversity of washington medicineWashington medicineWashington schoolTrophyu 01 trialPatients with metastatic urothelial cancerSacituzumab govitecan plus pembrolizumab

Gilead and Kite Oncology to Highlight Advances Supporting New Innovations in Cancer Care at the ASCO Annual Meeting

Gilead and Kite Oncology to Highlight Advances Supporting New Innovations in Cancer Care at the ASCO Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSanta monicaFoster cityJacquie rossMerdad parseyNathan kaiserFrank neumannAnna padulaRituximab rtxL axicabtagene ciloleucelAxicabtagene ciloleucelAzacitidine monotherapyGilead sciencesAmerican society of clinical oncologyKite global head of clinical developmentGilead sciences inc